These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39147318)

  • 1. ARNTL2 facilitates bladder cancer progression through potentiating ENO1-mediated glycolysis in a SLC31A1-independent and -dependent manner.
    Wang J; Ren J; Tu X; Yuan H; Ye Z; Wang X; Cui J; Wang J; Tang Y; Han P; Bai Y
    Life Sci; 2024 Oct; 355():122974. PubMed ID: 39147318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis.
    Shen D; Deng Z; Liu W; Zhou F; Fang Y; Shan D; Wang G; Qian K; Yu M; Zhang Y; Ju L; Xiao Y; Wang X
    Cell Death Dis; 2023 Apr; 14(4):246. PubMed ID: 37024456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer.
    Huang Z; Yan Y; Wang T; Wang Z; Cai J; Cao X; Yang C; Zhang F; Wu G; Shen B
    J Transl Med; 2022 Jul; 20(1):315. PubMed ID: 35836227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enolase-1 is a therapeutic target in endometrial carcinoma.
    Zhao M; Fang W; Wang Y; Guo S; Shu L; Wang L; Chen Y; Fu Q; Liu Y; Hua S; Fan Y; Liu Y; Deng X; Luo R; Mei Z; Jiang Q; Liu Z
    Oncotarget; 2015 Jun; 6(17):15610-27. PubMed ID: 25951350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revealing the potential of solute carrier family 31 (copper transporters), member 1: Insights into its role in bladder cancer progression and therapeutic implications.
    Lin YZ; Liu WH; Wu YP; Cai H; Zheng QS; Wei Y; Xu N; Xue XY
    Int J Immunopathol Pharmacol; 2024; 38():3946320241240706. PubMed ID: 38712735
    [No Abstract]   [Full Text] [Related]  

  • 6. Multi-omics reveals the role of ENO1 in bladder cancer and constructs an epithelial-related prognostic model to predict prognosis and efficacy.
    Su Z; You L; He Y; Chen J; Zhang G; Liu Z
    Sci Rep; 2024 Jan; 14(1):2189. PubMed ID: 38273010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulated ENO1 promotes the bladder cancer cell growth and proliferation via regulating β-catenin.
    Ji M; Wang Z; Chen J; Gu L; Chen M; Ding Y; Liu T
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31431517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination.
    Shen C; Liu J; Xie F; Yu Y; Ma X; Hu D; Liu C; Wang Y
    Cancer Lett; 2024 Jul; 595():217002. PubMed ID: 38823761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
    Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
    J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ENO1 contributes to the gemcitabine resistance of pancreatic cancer through the YAP1 signaling pathway.
    Ma H; Kong L; Liu L; Du Y; Zhu X; Wang J; Zhao W
    Mol Carcinog; 2024 Jul; 63(7):1221-1234. PubMed ID: 38517039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enolase 1 regulates stem cell-like properties in gastric cancer cells by stimulating glycolysis.
    Yang T; Shu X; Zhang HW; Sun LX; Yu L; Liu J; Sun LC; Yang ZH; Ran YL
    Cell Death Dis; 2020 Oct; 11(10):870. PubMed ID: 33067426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation.
    Zhang G; Zhao X; Liu W
    Cancer Biol Ther; 2022 Dec; 23(1):243-253. PubMed ID: 35316145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer.
    Zhan P; Zhao S; Yan H; Yin C; Xiao Y; Wang Y; Ni R; Chen W; Wei G; Zhang P
    Mol Carcinog; 2017 May; 56(5):1427-1437. PubMed ID: 27996156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WW domain-binding protein 2 acts as an oncogene by modulating the activity of the glycolytic enzyme ENO1 in glioma.
    Chen S; Zhang Y; Wang H; Zeng YY; Li Z; Li ML; Li FF; You J; Zhang ZM; Tzeng CM
    Cell Death Dis; 2018 Mar; 9(3):347. PubMed ID: 29497031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis.
    Hu T; Liu H; Liang Z; Wang F; Zhou C; Zheng X; Zhang Y; Song Y; Hu J; He X; Xiao J; King RJ; Wu X; Lan P
    Theranostics; 2020; 10(9):4056-4072. PubMed ID: 32226539
    [No Abstract]   [Full Text] [Related]  

  • 16. C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1.
    Ou B; Liu Y; Yang X; Xu X; Yan Y; Zhang J
    Cell Death Dis; 2021 Jul; 12(8):737. PubMed ID: 34312368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enolase1 overexpression regulates the growth of gastric cancer cells and predicts poor survival.
    Qiao H; Wang Y; Zhu B; Jiang L; Yuan W; Zhou Y; Guan Q
    J Cell Biochem; 2019 Nov; 120(11):18714-18723. PubMed ID: 31218757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salidroside Induces Apoptosis in Human Gastric Cancer Cells via the Downregulation of ENO1/PKM2/GLUT1 Expression.
    Dai Z; Zhang X; Li W; Tang J; Pan T; Ma C; Guan Q
    Biol Pharm Bull; 2021 Nov; 44(11):1724-1731. PubMed ID: 34471002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer.
    Qian X; Xu W; Xu J; Shi Q; Li J; Weng Y; Jiang Z; Feng L; Wang X; Zhou J; Jin H
    Oncotarget; 2017 Jul; 8(29):47691-47708. PubMed ID: 28548950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer.
    Deng T; Shen P; Li A; Zhang Z; Yang H; Deng X; Peng X; Hu Z; Tang Z; Liu J; Hou R; Liu Z; Fang W
    Theranostics; 2021; 11(16):8112-8128. PubMed ID: 34335983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.